Cangrelor use in a 6-year-old patient undergoing complex percutaneous coronary intervention after post-surgical myocardial infarction

Cangrelor use in a 6-year-old patient undergoing complex percutaneous coronary intervention after post-surgical myocardial infarction

Cangrelor is an intravenously administered P2Y12 receptor antagonist, which has been approved for adult patients undergoing percutaneous coronary intervention and, due to its unique pharmacokinetics, it allows effective and controllable peri-procedural platelet inhibition. We report the case of a 6-...

Full description

Bibliographic Details
Main Authors: Domenico Sirico, Nuccia Morici, Francesco Soriano, Stefano Maria Marianeschi, Giovanna Pedrazzini, Sergio Leonardi, Gabriele Vignati
Format: Article
Language:English
Published: Taylor & Francis Group 2020-11-01
Series:Platelets
Subjects:
cangrelor
congenital heart disease
coronary compression
myocardial infarction
pci
Online Access:http://dx.doi.org/10.1080/09537104.2020.1732323

Similar Items

Similar Items